vs
Side-by-side financial comparison of SEALED AIR CORP (SEE) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $1.4B, roughly 1.0× SEALED AIR CORP). SEALED AIR CORP runs the higher net margin — 3.1% vs 1.4%, a 1.7% gap on every dollar of revenue. On growth, SELECT MEDICAL HOLDINGS CORP posted the faster year-over-year revenue change (6.4% vs 2.6%). SEALED AIR CORP produced more free cash flow last quarter ($257.7M vs $5.2M). Over the past eight quarters, SELECT MEDICAL HOLDINGS CORP's revenue compounded faster (2.8% CAGR vs 2.7%).
Sealed Air Corporation is a global provider of innovative packaging and protective solutions. Its core offerings include cushioning materials, food safety and preservation packaging, and sustainable waste-reducing packaging systems, serving retail, e-commerce, food and beverage, and industrial manufacturing markets worldwide.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
SEE vs SEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.4B |
| Net Profit | $43.8M | $20.2M |
| Gross Margin | 28.6% | — |
| Operating Margin | 11.4% | 4.6% |
| Net Margin | 3.1% | 1.4% |
| Revenue YoY | 2.6% | 6.4% |
| Net Profit YoY | 700.0% | 225.7% |
| EPS (diluted) | $0.30 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4B | $1.4B | ||
| Q3 25 | $1.3B | $1.4B | ||
| Q2 25 | $1.3B | $1.3B | ||
| Q1 25 | $1.3B | $1.4B | ||
| Q4 24 | $1.4B | $1.3B | ||
| Q3 24 | $1.3B | $1.3B | ||
| Q2 24 | $1.3B | $1.3B | ||
| Q1 24 | $1.3B | $1.3B |
| Q4 25 | $43.8M | $20.2M | ||
| Q3 25 | $255.1M | $28.8M | ||
| Q2 25 | $93.1M | $40.6M | ||
| Q1 25 | $113.5M | $56.7M | ||
| Q4 24 | $-7.3M | $-16.1M | ||
| Q3 24 | $91.7M | $55.6M | ||
| Q2 24 | $98.3M | $77.6M | ||
| Q1 24 | $82.0M | $96.9M |
| Q4 25 | 28.6% | — | ||
| Q3 25 | 29.8% | — | ||
| Q2 25 | 30.7% | — | ||
| Q1 25 | 30.9% | — | ||
| Q4 24 | 30.0% | — | ||
| Q3 24 | 30.1% | — | ||
| Q2 24 | 31.2% | — | ||
| Q1 24 | 30.3% | — |
| Q4 25 | 11.4% | 4.6% | ||
| Q3 25 | 13.8% | 5.4% | ||
| Q2 25 | 15.0% | 6.5% | ||
| Q1 25 | 14.5% | 8.3% | ||
| Q4 24 | 11.7% | 1.6% | ||
| Q3 24 | 13.9% | 4.3% | ||
| Q2 24 | 15.4% | 5.8% | ||
| Q1 24 | 14.0% | 9.0% |
| Q4 25 | 3.1% | 1.4% | ||
| Q3 25 | 19.0% | 2.1% | ||
| Q2 25 | 7.0% | 3.0% | ||
| Q1 25 | 9.0% | 4.2% | ||
| Q4 24 | -0.5% | -1.2% | ||
| Q3 24 | 6.9% | 4.4% | ||
| Q2 24 | 7.4% | 6.1% | ||
| Q1 24 | 6.2% | 7.3% |
| Q4 25 | $0.30 | $0.17 | ||
| Q3 25 | $1.73 | $0.23 | ||
| Q2 25 | $0.63 | $0.32 | ||
| Q1 25 | $0.77 | $0.44 | ||
| Q4 24 | $-0.05 | $-0.12 | ||
| Q3 24 | $0.63 | $0.43 | ||
| Q2 24 | $0.67 | $0.60 | ||
| Q1 24 | $0.56 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $344.0M | $26.5M |
| Total DebtLower is stronger | $3.3B | $1.8B |
| Stockholders' EquityBook value | $1.2B | $1.7B |
| Total Assets | $7.0B | $5.9B |
| Debt / EquityLower = less leverage | 2.65× | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $344.0M | $26.5M | ||
| Q3 25 | $282.5M | $60.1M | ||
| Q2 25 | $354.4M | $52.3M | ||
| Q1 25 | $335.2M | $53.2M | ||
| Q4 24 | $371.8M | $59.7M | ||
| Q3 24 | $386.0M | $191.5M | ||
| Q2 24 | $388.6M | $111.2M | ||
| Q1 24 | $352.8M | $92.6M |
| Q4 25 | $3.3B | $1.8B | ||
| Q3 25 | $4.0B | $1.7B | ||
| Q2 25 | $4.0B | $1.8B | ||
| Q1 25 | $4.2B | $1.8B | ||
| Q4 24 | $4.2B | $1.7B | ||
| Q3 24 | $4.3B | $3.1B | ||
| Q2 24 | $4.4B | $3.6B | ||
| Q1 24 | $4.5B | $3.8B |
| Q4 25 | $1.2B | $1.7B | ||
| Q3 25 | $1.2B | $1.7B | ||
| Q2 25 | $953.1M | $1.7B | ||
| Q1 25 | $797.9M | $1.7B | ||
| Q4 24 | $624.5M | $1.7B | ||
| Q3 24 | $771.2M | $1.9B | ||
| Q2 24 | $650.1M | $1.4B | ||
| Q1 24 | $598.3M | $1.4B |
| Q4 25 | $7.0B | $5.9B | ||
| Q3 25 | $7.1B | $5.7B | ||
| Q2 25 | $7.2B | $5.7B | ||
| Q1 25 | $7.0B | $5.7B | ||
| Q4 24 | $7.0B | $5.6B | ||
| Q3 24 | $7.3B | $8.0B | ||
| Q2 24 | $7.3B | $7.9B | ||
| Q1 24 | $7.2B | $7.9B |
| Q4 25 | 2.65× | 1.06× | ||
| Q3 25 | 3.34× | 1.03× | ||
| Q2 25 | 4.18× | 1.10× | ||
| Q1 25 | 5.26× | 1.03× | ||
| Q4 24 | 6.72× | 1.01× | ||
| Q3 24 | 5.62× | 1.62× | ||
| Q2 24 | 6.81× | 2.54× | ||
| Q1 24 | 7.49× | 2.75× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $293.6M | $64.3M |
| Free Cash FlowOCF − Capex | $257.7M | $5.2M |
| FCF MarginFCF / Revenue | 18.5% | 0.4% |
| Capex IntensityCapex / Revenue | 2.6% | 4.2% |
| Cash ConversionOCF / Net Profit | 6.70× | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | $458.5M | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.6M | $64.3M | ||
| Q3 25 | $165.9M | $175.3M | ||
| Q2 25 | $136.6M | $110.3M | ||
| Q1 25 | $31.9M | $-3.5M | ||
| Q4 24 | $244.2M | $125.4M | ||
| Q3 24 | $170.5M | $181.0M | ||
| Q2 24 | $188.2M | $278.2M | ||
| Q1 24 | $125.1M | $-66.7M |
| Q4 25 | $257.7M | $5.2M | ||
| Q3 25 | $119.6M | $122.2M | ||
| Q2 25 | $93.2M | $45.6M | ||
| Q1 25 | $-12.0M | $-55.8M | ||
| Q4 24 | $185.1M | $62.0M | ||
| Q3 24 | $115.2M | $130.3M | ||
| Q2 24 | $129.5M | $222.6M | ||
| Q1 24 | $78.0M | $-119.2M |
| Q4 25 | 18.5% | 0.4% | ||
| Q3 25 | 8.9% | 9.0% | ||
| Q2 25 | 7.0% | 3.4% | ||
| Q1 25 | -0.9% | -4.1% | ||
| Q4 24 | 13.6% | 4.7% | ||
| Q3 24 | 8.6% | 10.2% | ||
| Q2 24 | 9.7% | 17.4% | ||
| Q1 24 | 5.9% | -9.0% |
| Q4 25 | 2.6% | 4.2% | ||
| Q3 25 | 3.4% | 3.9% | ||
| Q2 25 | 3.3% | 4.8% | ||
| Q1 25 | 3.5% | 3.9% | ||
| Q4 24 | 4.4% | 4.8% | ||
| Q3 24 | 4.1% | 4.0% | ||
| Q2 24 | 4.4% | 4.3% | ||
| Q1 24 | 3.6% | 4.0% |
| Q4 25 | 6.70× | 3.19× | ||
| Q3 25 | 0.65× | 6.09× | ||
| Q2 25 | 1.47× | 2.72× | ||
| Q1 25 | 0.28× | -0.06× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.86× | 3.25× | ||
| Q2 24 | 1.91× | 3.59× | ||
| Q1 24 | 1.53× | -0.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SEE
| Protective Segment | $1.1B | 78% |
| Other | $292.0M | 21% |
| Pension Plans Defined Benefit | $7.9M | 1% |
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
